Study number 8538-373
Dates
Feb 25 2025-Jul 10 2025
Location
Daytona Beach, Florida
Age
22-65
Gender
Male OR Female
Compensation
$16,688
Group
B3
The investigational drug in this research study is being developed for the potential treatment of type 2 diabetes mellitus, alongside diet, exercise, and oral medications. In addition, it is being developed for use as an aid to healthy diet and physical activity to manage body weight in adult patients with obesity or who are overweight. This study will also look at how the study drug affects smoking habits.
Fortrea Daytona Beach, FL is recruiting for:
- Healthy Men and Women of Non-childbearing potential, age 22-65
- Body Mass Index between 22-26.9* - Study involves 4 separate stays totaling 11 nights & 12 follow-up visits
- Compensation up to $16,688 may be provided for time and participation
- Refer a friend to receive $500 per qualified referral
* 60kg or more at screening
Call Now to Schedule Your Screening Appointment!
Cohort B3:
Check-in: Feb 25
Check-out: Mar 2
Follow up Visits: Mar 6, 13, 20
Check-in: Mar 26
Check-out: Mar 27
Follow up Visits: Apr 4, 10, 17
Check-in: Apr 23
Check-out: Apr 24
Follow up Visits: May 1, 8
Check-in: May 14
Check-out: May 18
Follow up Visits: May 22, 29, Jun 19, Jul 10